Nitrogen ( DrugBank: Nitrogen )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	1
299	嚢胞性線維症	2

6. パーキンソン病

---

臨床試験数 : 2,298 /  薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000010014	2013/02/28	13/02/2013	Randomized Double-blind, Placebo-controlled multi-center trial on molecular hydrogen water in Parkinson Disease		Parkinson's disesase	hydrogen water made by "Suisosui5.0" placebo-water (nitrogen filling water)	Juntendo University School of Medicine, Neurology	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	200	Not selected	Japan

299. 嚢胞性線維症

---

臨床試験数 : 1,696 /  薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02950116 (ClinicalTrials.gov)	March 9, 2017	11/10/2016	Lung Clearance Index (LCI) in Pediatric Patients With Obstructive Lung Disease	Lung Clearance Index in Pediatric Patients With Obstructive Lung Disease	Asthma;Bronchiectasis;Cystic Fibrosis	Device: Perform three multiple breath nitrogen washout tests (N2-MBW-test)	Universitair Ziekenhuis Brussel	NULL	Terminated	6 Years	17 Years	All	27	N/A	Belgium
2	NCT00570349 (ClinicalTrials.gov)	July 2004	6/12/2007	Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis	Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis	Cystic Fibrosis	Drug: Nitric Oxide for Inhalation;Drug: Nitrogen	Mallinckrodt	NULL	Completed	12 Years	N/A	All	18	Phase 1/Phase 2	United States